loadpatents
name:-0.008997917175293
name:-0.0075628757476807
name:-0.0027880668640137
FIELDHOUSE; Charlotte Patent Filings

FIELDHOUSE; Charlotte

Patent Applications and Registrations

Patent applications and USPTO patent grants for FIELDHOUSE; Charlotte.The latest application filed is for "pyridazinone compounds and their use as daao inhibitors".

Company Profile
3.13.17
  • FIELDHOUSE; Charlotte - Cambridge GB
  • Fieldhouse; Charlotte - Cambridgeshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20220008416 - FARNABY; William ;   et al.
2022-01-13
Pyrazole Derivatives As H4 Antagonist Compounds
App 20210300906 - Brown; Giles Albert ;   et al.
2021-09-30
Pyridazinone compounds and their use as DAAO inhibitors
Grant 11,129,828 - Farnaby , et al. September 28, 2
2021-09-28
1,2-substituted cyclopentanes as orexin receptor antagonists
Grant 10,689,373 - Fieldhouse , et al.
2020-06-23
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20200121678 - FARNABY; William ;   et al.
2020-04-23
Pyridazinone compounds and their use as DAAO inhibitors
Grant 10,463,663 - Farnaby , et al. No
2019-11-05
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists
App 20180282309 - Fieldhouse; Charlotte ;   et al.
2018-10-04
1,2-substituted cyclopentanes as orexin receptor antagonists
Grant 10,011,588 - Fieldhouse , et al. July 3, 2
2018-07-03
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20180177780 - FARNABY; William ;   et al.
2018-06-28
Pyridazinone compounds and their use as DAAO inhibitors
Grant 9,931,340 - Farnaby , et al. April 3, 2
2018-04-03
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
Grant 9,790,220 - Fieldhouse , et al. October 17, 2
2017-10-17
Pyridazinones as DAAO enzyme inhibitors
Grant 9,750,748 - Farnaby , et al. September 5, 2
2017-09-05
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20170173007 - FARNABY; William ;   et al.
2017-06-22
Substituted Cyclopentanes, Tetrahydrofuranes And Pyrrolidines As Orexin Receptor Antagonists
App 20170073340 - Fieldhouse; Charlotte ;   et al.
2017-03-16
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists
App 20170066744 - Fieldhouse; Charlotte ;   et al.
2017-03-09
Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
Grant 9,493,432 - Fieldhouse , et al. November 15, 2
2016-11-15
Cyclopentylbenzamide Derivatives and their Use for the Treatment of Psychotic and Cognitive Disorders
App 20160222030 - Fieldhouse; Charlotte ;   et al.
2016-08-04
Pyridazinone compounds and their use as DAAO inhibitors
Grant 9,290,456 - Farnaby , et al. March 22, 2
2016-03-22
Pyridazinones As Daao Enzyme Inhibitors
App 20150329495 - FARNABY; William ;   et al.
2015-11-19
5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain
Grant 9,180,122 - Farnaby , et al. November 10, 2
2015-11-10
Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists
Grant 9,156,829 - Fieldhouse , et al. October 13, 2
2015-10-13
Novel Compounds
App 20150232460 - Fieldhouse; Charlotte ;   et al.
2015-08-20
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20150030704 - Farnaby; William ;   et al.
2015-01-29
5- Or 6-substituted 3-hydroxy-2(1h)-pyridinones As D-amino Acid Oxidase (daao) Inhibitors In Therapy Of Diseases Such As Schizophrenia, Cognitive Disorder And Paid
App 20140243353 - Farnaby; William ;   et al.
2014-08-28
Novel Compounds
App 20130052281 - FARNABY; William ;   et al.
2013-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed